Showing results (91-100 of 444) with videos related to

Sort By:
Pageof 45
International Dental Journal|January 4, 2026
Prompt-Driven ChatGPT Carbon Calculator for Dental Practices: Estimation and Tailored Improvement StrategiesBrett Duane, Paul Ashley, James Larkin
Expert Review of Anticancer Therapy|October 15, 2010
Does axitinib (AG-01376) have a future role in metastatic renal cell carcinoma and other malignancies?Robert Goldstein, Lisa Pickering, James Larkin
Irish Journal of Medical Science|September 3, 2021
Diagnostic coding of chronic physical conditions in Irish general practiceIvana Pericin, James Larkin, Claire Collins
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Challenging the treatment paradigm for advanced renal cell carcinoma: a review of systemic and localized therapiesAxel Bex, James Larkin, Martin Voss
Health Policy (Amsterdam, Netherlands)|August 25, 2021
Payments reported by the pharmaceutical industry in Ireland from 2015 to 2019: An observational studyFrank Moriarty, James Larkin, Tom Fahey
The Lancet. Oncology|July 12, 2017
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysisSamra Turajlic, Kevin Litchfield, Hang Xu, et al.
Expert Opinion on Investigational Drugs|May 14, 2020
Metastatic melanoma: therapeutic agents in preclinical and early clinical developmentLaura Amanda Boos, Isla Leslie, James Larkin
Expert Review of Anticancer Therapy|December 14, 2021
Atezolizumab, cobimetinib, and vemurafenib as first-line treatment for unresectable metastatic BRAF V600 mutated melanomaAndreas M Schmitt, Lucy Dumas, James Larkin
Expert Opinion on Drug Safety|May 1, 2015
Safety of pembrolizumab for the treatment of melanomaJuan Martin-Liberal, Tiana Kordbacheh, James Larkin
Pageof 45